biostudies-literatureUnknown8(10)Bakesiima RNORHED funded SURVIVAL-PLUSS Project<h4>Objective</h4>To determine the prevalence and factors associated with dyslipidaemias in women using hormonal contraceptives.<h4>Design</h4>Cross-sectional study SETTING: Mulago Hospital, Kampala, Uganda PARTICIPANTS: Three hundred and eighty-four consenting women, aged 18-49 years, who had used hormonal contraceptives for at least 3 months prior to the study.<h4>Study outcome</h4>Dyslipidaemias (defined as derangements in lipid profile levels which included total cholesterol ≥200 mg/dL, high-density lipoprotein <40 mg/dL, triglyceride >150 mg/dL or low-density lipoprotein ≥160 mg/dL) for which the prevalence and associated factors were obtained.<h4>Results</h4>The prevalence of dyslipidaemias was 63.3% (95% CI: 58.4 to 68.1). Body mass index (BMI) (PR=1.33, 95% CI: 1.15 to 1.54, p<0.00BMJ opene022338https://www.ebi.ac.uk/biostudies/studies/S-EPMC6196835biostudies-literatureDyslipidaemias in women using hormonal contraceptives: a cross sectional study in Mulago Hospital Family Planning Clinic, Kampala, Uganda.PMC6196835Tumwine JKNajjingo IKaramagi CNabaasa GByakika-Kibwika PNabaggala GSKalyango JNOlweny FBakesiima RfalseDyslipidaemias in women using hormonal contraceptives: a cross sectional study in Mulago Hospital Family Planning Clinic, Kampala, Uganda.<h4>Objective</h4>To determine the prevalence and factors associated with dyslipidaemias in women using hormonal contraceptives.<h4>Design</h4>Cross-sectional study SETTING: Mulago Hospital, Kampala, Uganda PARTICIPANTS: Three hundred and eighty-four consenting women, aged 18-49 years, who had used hormonal contraceptives for at least 3 months prior to the study.<h4>Study outcome</h4>Dyslipidaemias (defined as derangements in lipid profile levels which included total cholesterol ≥200 mg/dL, high-density lipoprotein <40 mg/dL, triglyceride >150 mg/dL or low-density lipoprotein ≥160 mg/dL) for which the prevalence and associated factors were obtained.<h4>Results</h4>The prevalence of dyslipidaemias was 63.3% (95% CI: 58.4 to 68.1). Body mass index (BMI) (PR=1.33, 95% CI: 1.15 to 1.54, p<0.002018-01-01T00:00:00Z2018 Oct2026-06-06T20:37:32.768Z2019-03-27T00:04:10ZS-EPMC61968353034112610.1136/bmjopen-2018-022338